DEC-C Post-Transplant

A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Arms / Cohorts

Experimental:Phase 1 Dose Level 1: DEC-C

Accepting patients

Experimental:Phase 1 Dose Level 2: DEC-C

Accepting patients

Experimental:Phase 2 MRD Positive: DEC-C

Accepting patients

Observational, Active Comparator Arm:Phase 2: MRD Negative

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.